title: Changes in plasma glucose in Otsuka Long-Evans Tokushima Fatty rats after oral administration of maple syrup.
abstract: We investigate whether maple syrup is a suitable sweetener in the management of type 2 diabetes using the Otsuka Long-Evans Tokushima Fatty (OLETF) rat. The enhancement in plasma glucose (PG) and glucose absorption in the small intestine were lower after the oral administration of maple syrup than after sucrose administration in OLETF rats, and no significant differences were observed in insulin levels. These data suggested that maple syrup might inhibit the absorption of glucose from the small intestine and preventing the enhancement of PG in OLETF rats. Therefore, maple syrup might help in the prevention of type 2 diabetes.
authors.affiliation: Faculty of Pharmacy, Kinki University.
authors.forename: Noriaki
authors.initials: N
authors.lastname: Nagai
authors.forename: Tetsushi
authors.initials: T
authors.lastname: Yamamoto
authors.forename: Wataru
authors.initials: W
authors.lastname: Tanabe
authors.forename: Yoshimasa
authors.initials: Y
authors.lastname: Ito
authors.forename: Satoshi
authors.initials: S
authors.lastname: Kurabuchi
authors.forename: Kuniko
authors.initials: K
authors.lastname: Mitamura
authors.forename: Atsushi
authors.initials: A
authors.lastname: Taga
mesh_terms: D031002:Acer; D000284:Administration, Oral; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D003864:Depression, Chemical; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control; D007408:Intestinal Absorption / Q000187:drug effects; D007421:Intestine, Small / Q000378:metabolism; D008297:Male; D020334:Rats, Inbred OLETF; D017208:Rats, Wistar; D013549:Sweetening Agents / Q000008:administration & dosage* / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D013549:Sweetening Agents